MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3374-3381

  White, Katherine L ^a,b   Snyder, Heidi Link ^a,b,c   Krzych, Urszula ^a,b  

^a CATHOLIC UNIVERSITY OF AMERICA   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 MICROGLOBULIN; CD8 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 2; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; FEMALE; LYMPHOCYTE PROLIFERATION; MALARIA; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PRIORITY JOURNAL; SPOROZOITE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, PROTOZOAN; BETA 2-MICROGLOBULIN; CD8-POSITIVE T-LYMPHOCYTES; ERYTHROCYTES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; IMMUNOTHERAPY, ADOPTIVE; MALARIA; MALARIA VACCINES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLASMODIUM BERGHEI; SPLEEN; VACCINES, ATTENUATED;

EID: 0029883981     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Good, M. F. 1995. Development of immunity to malaria may not be an entirely active process. Parasite Immunol. 17:55.
2. Mercereau-Puijalon, O., T. Fandeur, M. Guillotte, and S. Bonnefoy. 1991. Parasite features impeding malaria immunity: antigenic diversity, antigenic variation, and poor immunogenicity. Res. Immunol. 142:690.
3. Clyde, D. F., H. Most, V. C. McCarthy, and J. P. Vanderberg. 1973. Immunization of man against sporozoite-induced Plasmodium falciparum malaria. Am. J. Med. Sci. 266:169.
4. Nussenzweig, R., J. Vanderberg, and H. Most. 1969. Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity, and humoral immunity. Mil. Med. 134:1176.
5. Nardin, E. H., and R. S. Nussenzweig. 1993. T cell responses to pre-erythrocytic stages of malaria. Role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11:687.
6. + cytolytic T cell clone confers protection against murine malaria. J. Exp. Med. 172:1353.
7. Scheller, L. F., and A. F. Azad. 1995. Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. Proc. Natl. Acad. Sci. USA 92:4066.
8. Krzych, U., J. A. Lyon, T. Jareed, I. Schneider, M. R. Hollingdale, D. M. Gordon, and W. R. Ballou. 1995. T lymphocytes from volunteers immunized with irradiated Plasmodium falciparum sporozoites recognize liver and blood stage malaria antigens. J. Immunol. 155:4077.
9. + T cells in immunity to malaria sporozoites. J. Immunol. 51:2690.
10. Shear, H. L., R. Srinivasan, T. Nolan, and N. Chui. 1989. Role of IFN-γ lethal and nonlethal malaria in susceptible and resistant murine hosts. J. Immunol. 143: 2038.
11. Kremsner, P. G., S. Neifer, S. Schermuck, M. F. Chaves, K. Sliwa, and U. Bienzle. 1991. Interferon-γ enhances the effect of anti-malarial chemotherapy in murine Plasmodium vinckei malara. J. Infect. Dis. 163:1161.
12. Nussler, A., J. Drapier, L. Renia, S. Pied, F. Miltgen, M. Gentlini, and D. Mazier. 1991. L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin-6 stimulation. Eur. J. Immunol. 21:227.
13. Potocnjak, P., N. Yoshida, and V. Nussenzweig. 1980. Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malarial infection. J. Exp. Med. 151:1504.
14. Romero, P., J. L. Maryanski, G. Corradin, R. S. Nussenzweig, and V. Nussenzweig. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323.
15. Weiss, W. A., S. Mellouk, R. A. Houghten, M. Sedegah, S. Kumar, M. F. Good, J. A. Berzofsky, L. H. Miller, and S. L. Hoffman. 1990. Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med. 171:763.
16. Khusmith, S., Y. Charoenvit, S. Kumar, M. Sedegah, R. Beaudoin, and S. Hoffman. 1991. Protection against malaria by vaccination with sporozoite surface protein-2 plus CS protein. Science 252:715.
17. + cytoloxic T lymphocyte epitope on the Plasmodium falciparum circumsporozoite protein. Infect. Immun. 63:1955.
18. Malik, A., J. E. Egan, R. A. Houghten, J. C. Sadoff, and S. L. Hoffman. 1991. Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. Proc. Natl. Acad. Sci. USA 88:3300.
19. Wizel, B., R. Houghten, P. Church, J. A. Tine, D. E. Lanar, D. M. Gordon, W. R. Ballou, A. Sette, and S. L. Hoffman. 1995. HLA-A2-restricted cytotoxic T lymphocyte responses to multiple Plasmodium falciparum sporozoite surface protein-2 epitopes in sporozoite-immunized volunteers. J. Immunol. 155:766.
20. Hill, A. V., J. Elvin, A. C. Willis, M. Aidoo, C. E. Allsopp, F. M. Gotch, X. M. Gao, M. Takiguchi, B. M. Greenwood, and A. R. Townsend. 1992. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 360:434.
21. + T cells, and antibodies required for immunity to malaria sporozoites. Nature 330:664.
22. + T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. Proc. Natl. Acad. Sci. USA 85:573.
23. Weiss, W. R., J. A. Berzofsky, R. Houghten, M. Sedegah, M. Hollingdale, and S. L. Hoffman. 1992. A T cell clone directed at the circumsporozoite protein which protects against Plasmodium yoelii and Plasmodium berghei. J. Immunol. 149:2103.
24. Romero, P., J. L. Maryanski, G. Corradin, R. S. Nussenzweig, V. Nussenzweig, and F. Zavala. 1989. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature 341:323.
25. 2-microglobulin locus in mouse embryonic stem cells by homologous recombination. Proc. Natl. Acad. Sci. USA 86:8932.
26. Mozes, E., L. D. Kohn, F. Hakim, and D. S. Singer. 1993. Resistance of MHC class I-deficient mice to experimental systemic lupus erythematosus. Science 261:91.
27. + cytotoxic T lymphocytes that mediate specific tumor rejection. J. Immunol. 151:6283.
28. + T cells. J. Exp. Med. 174:875.
29. 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase. J. Immunol. 150:5484.
30. 2-microglobulin-deficient mice. Science 255:1576.
31. + cells as effectors of IFN-γ-dependent immunity to Toxoplasma gondii in class I-deficient mice. J. Exp. Med. 178:1465.
32. 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338.
33. Link, H., W. R. Ballou, and U. Krzych. 1990. Immune response to Plasmodium berghei sporozoite antigens. I. Evaluation of murine T cell repertoire following immunization with irradiated sporozoites. Am. J. Trop. Med. Hyg. 43:452.
34. White, K. L., D. L. Jarboe, and U. Krzych. 1994. Immunization with irradiated Plasmodium berghei sporozoites induces interleukin-2 and interferon-γ but not interleukin-4. Parasite Immunol. 16:479.
35. Gordon, D. M., T. M. Cosgriff, I. Schneider, G. F. Wasserman, W. R. Majarian, M. R. Hollingdale, and J. D. Chulay. 1990. Safety and immunogenicity of a Plasmodium vivax sporozoite vaccine. Am. J. Trop. Med. Hyg. 42:527.
36. von Boemer, H. 1992. Thymic selection: a matter of life and death. Immunol. Today 13:454.
37. Yewdell, J. W., and J. R. Bennink. 1992. Cell biology of antigen processing and presentation to major histocompatibility complex I molecule-restricted T lymphocytes. Adv. Immunol. 52:1.
38. Hunt, D. F., R. A. Henderson, J. Shabanowitz, K. Sakaguchi, H. Michel, N. Sevilir, A. L. Cox, E. Appella, and V. H. Engelhard. 1992. Characteristics of peptides bound to the MHC molecule HLA-A.1 by mass spectrometry. Science 255:1261.
39. + cytolytic T cell clones derived against Plasmodium circumsporozoite protein protect against malaria. Int. Immunol. 3:579.
40. 2-microglobulin during de novo synthesis and irreversible by exchange or dissociation. J. Immunol. 142:2751.
41. Porcelli, S. A., and R. L. Modlin. 1995. CD1 antigens and the expanding universe of T cell antigens. J. Immunol. 155:3709.
42. + T cells in major histocompatibility complex class II-deficient mice. J. Exp. Med. 182:993.
43. Tsuji, M., Y. Miyahira, R. S. Nussenzweig, M. Aguet, M. Reichel, and F. Zavala. 1995. Development of antimalaria immunity in mice lacking IFN-γ receptor 1. J. Immunol. 154:5338.
44. + T cell clones against Plasmodium yoelii liver stages. J. Immunol. 150:1471.
45. Hoffman, S. L., D. Isenbarger, G. W. Long, M. Sedegah, A. Szarfman, L. Waters, M. R. Hollingdale, P. H. van der Meide, D. S. Finbloom, and W. R. Ballou. 1988. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244:1078.
46. - γδ T cell subset in the spleens of mice during nonlethal blood-stage malaria. Eur. J. Immunol. 23:182.
47. van der Heyde, H. C., M. M. Elloso, W. L. Chang, and M. Kaplan. 1995. γδ T cells function in cell-mediated immunity to acute blood-stage Plasmodium chabaudi adami malaria. J. Immunol. 154:3985.
48. Liao, N., M. Bix, M. Zijlstra, R. Jaenisch, and D. Raulet. 1991. MHC class I deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science 253:199.
49. He, W., and D. Kabelitz. 1995. Differential effects of interleukin-2 and interleukin-7 on the induction of CD4 and CD8 expression by double-negative human thymocytes. Scand. J. Immunol. 41:309.
50. 0/0 mice. J. Immunol. 151:3187.